Dicerna Pharmaceuticals
DRNA
#3627
Rank
A$4.52 B
Marketcap
$58.04
Share price
0.00%
Change (1 day)
16,683.58%
Change (1 year)

Earnings for Dicerna Pharmaceuticals (DRNA)

Earnings in 2021 (TTM): -A$0.16 Billion

According to Dicerna Pharmaceuticals's latest financial reports the company's current earnings are A$0.19 Billion. In 2020 the company made an earning of -A$0.17 Billion, an increase over its 2019 earnings that were of -A$0.19 Billion.

Earnings history for Dicerna Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-A$0.16 Billion-5.12%
2020-A$0.17 Billion-11.52%
2019-A$0.19 Billion38.33%
2018-A$0.14 Billion46.14%
2017-A$92.01 Million1.8%
2016-A$90.38 Million-5.58%
2015-A$95.72 Million32.01%
2014-A$72.51 Million171.79%
2013-A$26.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$53.15 Million-70.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.8 Billion 346.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.85 Billion 930.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.29 Billion 58.84%๐Ÿ‡บ๐Ÿ‡ธ USA
A$25.04 B-14,115.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.10 B-4,076.98%๐Ÿ‡บ๐Ÿ‡ธ USA